2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Journal of the American College of Cardiology - Tập 70 Số 2 - Trang 252-289 - 2017
Yogesh N.V. Reddy, Catherine M Otto, Robert O. Bonow, Blasé A. Carabello, John P. Erwin, Lee A. Fleisher, Hani Jneid, Michael J. Mack, Christopher J. McLeod, Patrick T. O’Gara, Vera H. Rigolin, Thoralf M. Sundt, Annemarie Thompson

Tóm tắt

Từ khóa


Tài liệu tham khảo

Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (U.S.). Clinical Practice Guidelines We Can Trust. ed. Washington, DC: Press NA, 2011.

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (U.S.). Finding What Works in Health Care: Standards for Systematic Reviews. ed. Washington, DC: Press NA, 2011.

Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016

2010, Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines, American College of Cardiology and American Heart Association

Halperin, 2016, Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 67, 1572, 10.1016/j.jacc.2015.09.001

Jacobs, 2013, ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, 213, 10.1016/j.jacc.2012.09.025

Jacobs, 2014, The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, 1373, 10.1016/j.jacc.2014.06.001

Arnett, 2014, J Am Coll Cardiol, 64, 1851, 10.1016/j.jacc.2014.07.012

Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2438, 10.1016/j.jacc.2014.02.537

Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, e57, 10.1016/j.jacc.2014.02.536

Wilson, 2007, Circulation, 116, 1736, 10.1161/CIRCULATIONAHA.106.183095

Habib, 2015, 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC), Eur Heart J, 36, 3075, 10.1093/eurheartj/ehv319

Glenny, 2013, Antibiotics for the prophylaxis of bacterial endocarditis in dentistry, Cochrane Database Syst Rev, CD003813

(NICE) UNIfHaCE. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. Available at: https://www.nice.org.uk/guidance/cg64. Accessed January 20, 2017.

Mougeot, 2015, Associations between bacteremia from oral sources and distant-site infections: tooth brushing versus single tooth extraction, Oral Surg Oral Med Oral Pathol Oral Radiol, 119, 430, 10.1016/j.oooo.2015.01.009

Desimone, 2012, Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines, Circulation, 126, 60, 10.1161/CIRCULATIONAHA.112.095281

Dayer, 2015, Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis, Lancet, 385, 1219, 10.1016/S0140-6736(14)62007-9

Duval, 2012, Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys, J Am Coll Cardiol, 59, 1968, 10.1016/j.jacc.2012.02.029

Pasquali, 2012, Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines, Am Heart J, 163, 894, 10.1016/j.ahj.2012.03.002

Pant, 2015, Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011, J Am Coll Cardiol, 65, 2070, 10.1016/j.jacc.2015.03.518

Thornhill, 2011, Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study, BMJ, 342, d2392, 10.1136/bmj.d2392

Strom, 2000, Risk factors for infective endocarditis: oral hygiene and nondental exposures, Circulation, 102, 2842, 10.1161/01.CIR.102.23.2842

Sherman-Weber, 2004, Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature, Transpl Infect Dis, 6, 165, 10.1111/j.1399-3062.2004.00074.x

Lockhart, 2008, Bacteremia associated with toothbrushing and dental extraction, Circulation, 117, 3118, 10.1161/CIRCULATIONAHA.107.758524

Geist, 2007, American Heart Association 2007 guidelines on prevention of infective endocarditis, J Mich Dent Assoc, 89, 50

Duval, 2006, Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis, Clin Infect Dis, 42, e102, 10.1086/504385

2015, The 2015 ESC Guidelines for the management of infective endocarditis, Eur Heart J, 36, 3036

Horstkotte, 1987, Contribution for choosing the optimal prophylaxis of bacterial endocarditis, Eur Heart J, 8, 379, 10.1093/eurheartj/8.suppl_J.379

Strom, 1998, Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study, Ann Intern Med, 129, 761, 10.7326/0003-4819-129-10-199811150-00002

Amat-Santos, 2015, Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry, Circulation, 131, 1566, 10.1161/CIRCULATIONAHA.114.014089

Mangner, 2016, Incidence, predictors, and outcome of patients developing infective endocarditis following transfemoral transcatheter aortic valve replacement, J Am Coll Cardiol, 67, 2907, 10.1016/j.jacc.2016.03.588

Karavas, 2002, Risk factors and management of endocarditis after mitral valve repair, J Heart Valve Dis, 11, 660

Gillinov, 2002, Endocarditis after mitral valve repair, Ann Thorac Surg, 73, 1813, 10.1016/S0003-4975(02)03551-8

Pérez-Gómez, 2004, Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study, J Am Coll Cardiol, 44, 1557, 10.1016/j.jacc.2004.05.084

Noseworthy, 2016, Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease, Int J Cardiol, 209, 181, 10.1016/j.ijcard.2016.02.005

Avezum, 2015, Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, Circulation, 132, 624, 10.1161/CIRCULATIONAHA.114.014807

Breithardt, 2014, Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial, Eur Heart J, 35, 3377, 10.1093/eurheartj/ehu305

Ezekowitz, 2016, Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy), Circulation, 134, 589, 10.1161/CIRCULATIONAHA.115.020950

Aguilar, 2005, Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks, Cochrane Database Syst Rev, CD001927

Olesen, 2011, Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study, BMJ, 342, d124, 10.1136/bmj.d124

Lytvyn, 2016, Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review, BMJ Open, 6, e014327, 10.1136/bmjopen-2016-014327

Horstkotte, 1988, The natural history of aortic valve stenosis, Eur Heart J, 9, 57, 10.1093/eurheartj/9.suppl_E.57

O’Brien, 2009, The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery, Ann Thorac Surg, 88, S23, 10.1016/j.athoracsur.2009.05.056

Freeman, 2005, Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies, Circulation, 111, 3316, 10.1161/CIRCULATIONAHA.104.486738

Kvidal, 2000, Observed and relative survival after aortic valve replacement, J Am Coll Cardiol, 35, 747, 10.1016/S0735-1097(99)00584-7

Murphy, 1981, Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement, Circulation, 64, II184

Rosenhek, 2012, Aortic stenosis: disease severity, progression, timing of intervention and role in monitoring transcatheter valve implanation, 425

Schwarz, 1982, The effect of aortic valve replacement on survival, Circulation, 66, 1105, 10.1161/01.CIR.66.5.1105

Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590

Mack, 2015, 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2477, 10.1016/S0140-6736(15)60308-7

Deeb, 2016, Three-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement, J Am Coll Cardiol, 67, 2565, 10.1016/j.jacc.2016.03.506

Holmes, 2015, Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry, J Am Coll Cardiol, 66, 2813, 10.1016/j.jacc.2015.10.021

Makkar, 2012, Transcatheter aortic-valve replacement for inoperable severe aortic stenosis, N Engl J Med, 366, 1696, 10.1056/NEJMoa1202277

Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510

Eltchaninoff, 2011, Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry, Eur Heart J, 32, 191, 10.1093/eurheartj/ehq261

Rodés-Cabau, 2012, Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience, J Am Coll Cardiol, 60, 1864, 10.1016/j.jacc.2012.08.960

Abdel-Wahab, 2015, One-year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial, J Am Coll Cardiol, 66, 791, 10.1016/j.jacc.2015.06.026

Kapadia, 2015, 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2485, 10.1016/S0140-6736(15)60290-2

Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J Am Coll Cardiol, 63, 1972, 10.1016/j.jacc.2014.02.556

Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232

Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384

Leon, 2016, Transcatheter or surgical aortic-valve replacement in intermediate-risk patients, N Engl J Med, 374, 1609, 10.1056/NEJMoa1514616

Thourani, 2016, Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis, Lancet, 387, 2218, 10.1016/S0140-6736(16)30073-3

Siemieniuk, 2016, Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis, BMJ, 354, i5130, 10.1136/bmj.i5130

Foroutan, 2016, Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies, BMJ, 354, i5065, 10.1136/bmj.i5065

Vandvik, 2016, Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline, BMJ, 354, i5085, 10.1136/bmj.i5085

Uretsky, 2015, Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial, J Am Coll Cardiol, 65, 1078, 10.1016/j.jacc.2014.12.047

Grayburn, 2014, Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach, J Am Coll Cardiol, 64, 2792, 10.1016/j.jacc.2014.10.016

Acker, 2014, Mitral-valve repair versus replacement for severe ischemic mitral regurgitation, N Engl J Med, 370, 23, 10.1056/NEJMoa1312808

Goldstein, 2016, Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation, N Engl J Med, 374, 344, 10.1056/NEJMoa1512913

Michler, 2016, Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation, N Engl J Med, 374, 1932, 10.1056/NEJMoa1602003

Smith, 2014, Surgical treatment of moderate ischemic mitral regurgitation, N Engl J Med, 371, 2178, 10.1056/NEJMoa1410490

David, 2013, Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease, Circulation, 127, 1485, 10.1161/CIRCULATIONAHA.112.000699

Gillinov, 2010, Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop?, Ann Thorac Surg, 90, 481, 10.1016/j.athoracsur.2010.03.101

Tribouilloy, 1999, Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications, Circulation, 99, 400, 10.1161/01.CIR.99.3.400

Crawford, 1990, Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease, Circulation, 81, 1173, 10.1161/01.CIR.81.4.1173

Enriquez-Sarano, 1994, Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications, J Am Coll Cardiol, 24, 1536, 10.1016/0735-1097(94)90151-1

Grigioni, 1999, Sudden death in mitral regurgitation due to flail leaflet, J Am Coll Cardiol, 34, 2078, 10.1016/S0735-1097(99)00474-X

Grigioni, 2008, Outcomes in mitral regurgitation due to flail leaflets a multicenter European study, J Am Coll Cardiol Img, 1, 133, 10.1016/j.jcmg.2007.12.005

Schuler, 1979, Temporal response of left ventricular performance to mitral valve surgery, Circulation, 59, 1218, 10.1161/01.CIR.59.6.1218

Starling, 1995, Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation, Circulation, 92, 811, 10.1161/01.CIR.92.4.811

Tribouilloy, 2009, Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study, J Am Coll Cardiol, 54, 1961, 10.1016/j.jacc.2009.06.047

STS online risk calculator. Available at: http://riskcalcstsorg/stswebriskcalc Accessed January 20, 2017.

Braunberger, 2001, Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency, Circulation, 104, I8, 10.1161/01.CIR.104.suppl_1.I-8

Cohn, 1988, Surgery for mitral regurgitation, JAMA, 260, 2883, 10.1001/jama.1988.03410190131036

Cosgrove, 1986, Results of mitral valve reconstruction, Circulation, 74, I82

David, 1983, The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation, Circulation, 68, II76

David, 1984, Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae, J Thorac Cardiovasc Surg, 88, 718, 10.1016/S0022-5223(19)35439-X

David, 2005, A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse, J Thorac Cardiovasc Surg, 130, 1242, 10.1016/j.jtcvs.2005.06.046

Gammie, 2009, Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, Ann Thorac Surg, 87, 1431, 10.1016/j.athoracsur.2009.01.064

Goldman, 2006, Dental management of patients with bone marrow and solid organ transplantation, Dent Clin North Am, 50, 659, 10.1016/j.cden.2006.06.009

Hansen, 1989, Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance, J Thorac Cardiovasc Surg, 97, 521, 10.1016/S0022-5223(19)34542-8

Hennein, 1990, Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement, J Thorac Cardiovasc Surg, 99, 828, 10.1016/S0022-5223(19)36897-7

Horskotte, 1993, The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study, J Heart Valve Dis, 2, 150

McClure, 2013, One thousand minimally invasive mitral valve operations: early outcomes, late outcomes, and echocardiographic follow-up, J Thorac Cardiovasc Surg, 145, 1199, 10.1016/j.jtcvs.2012.12.070

Rozich, 1992, Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance, Circulation, 86, 1718, 10.1161/01.CIR.86.6.1718

Rushmer, 1956, Initial phase of ventricular systole: asynchronous contraction, Am J Physiol, 184, 188, 10.1152/ajplegacy.1955.184.1.188

Sarris, 1988, Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction, J Thorac Cardiovasc Surg, 95, 969, 10.1016/S0022-5223(19)35662-4

Vassileva, 2013, Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries, Circulation, 127, 1870, 10.1161/CIRCULATIONAHA.113.002200

Badhwar, 2012, Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007, Ann Thorac Surg, 94, 1870, 10.1016/j.athoracsur.2012.05.105

Bolling, 2010, Predictors of mitral valve repair: clinical and surgeon factors, Ann Thorac Surg, 90, 1904, 10.1016/j.athoracsur.2010.07.062

Chauvaud, 2001, Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency, Circulation, 104, I12, 10.1161/hc37t1.094707

Chikwe, 2011, A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians, Eur Heart J, 32, 618, 10.1093/eurheartj/ehq331

Grossi, 1998, Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated?, J Thorac Cardiovasc Surg, 115, 389, 10.1016/S0022-5223(98)70283-1

Gillinov, 2003, Mitral valve repair with aortic valve replacement is superior to double valve replacement, J Thorac Cardiovasc Surg, 125, 1372, 10.1016/S0022-5223(02)73225-X

Suri, 2013, Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets, JAMA, 310, 609, 10.1001/jama.2013.8643

Rosenhek, 2006, Outcome of watchful waiting in asymptomatic severe mitral regurgitation, Circulation, 113, 2238, 10.1161/CIRCULATIONAHA.105.599175

Gillinov, 2008, Valve repair versus valve replacement for degenerative mitral valve disease, J Thorac Cardiovasc Surg, 135, 885, 10.1016/j.jtcvs.2007.11.039

Duran, 1994, Valve repair in rheumatic mitral disease: an unsolved problem, J Card Surg, 9, 282, 10.1111/j.1540-8191.1994.tb00942.x

Suri, 2009, Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse, J Thorac Cardiovasc Surg, 137, 1071, 10.1016/j.jtcvs.2008.10.026

Kang, 2009, Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation, Circulation, 119, 797, 10.1161/CIRCULATIONAHA.108.802314

Tribouilloy, 2011, Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction, Eur J Echocardiogr, 12, 702, 10.1093/ejechocard/jer128

Enriquez-Sarano, 2015, Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation, J Thorac Cardiovasc Surg, 150, 50, 10.1016/j.jtcvs.2015.04.009

Quintana, 2014, Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function, J Thorac Cardiovasc Surg, 148, 2752, 10.1016/j.jtcvs.2014.07.029

Suri, 2008, Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation, J Thorac Cardiovasc Surg, 136, 442, 10.1016/j.jtcvs.2007.10.067

Naji, 2014, Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation, J Am Heart Assoc, 3, e001010, 10.1161/JAHA.114.001010

Cox, 1991, The surgical treatment of atrial fibrillation. IV. Surgical technique, J Thorac Cardiovasc Surg, 101, 584, 10.1016/S0022-5223(19)36685-1

Ghoreishi, 2011, Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery, J Thorac Cardiovasc Surg, 142, 1439, 10.1016/j.jtcvs.2011.08.030

Kawaguchi, 1996, Risks and benefits of combined maze procedure for atrial fibrillation associated with organic heart disease, J Am Coll Cardiol, 28, 985, 10.1016/S0735-1097(96)00275-6

Kobayashi, 1996, Rationale of the Cox Maze procedure for atrial fibrillation during redo mitral valve operations, J Thorac Cardiovasc Surg, 112, 1216, 10.1016/S0022-5223(96)70134-4

Ngaage, 2007, Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?, Ann Thorac Surg, 84, 434, 10.1016/j.athoracsur.2007.04.036

Olasinska-Wisniewska, 2012, Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations, Ann Thorac Surg, 93, 1449, 10.1016/j.athoracsur.2011.12.034

Raine, 2004, Effect of mitral valve repair/replacement surgery on atrial arrhythmia behavior, J Heart Valve Dis, 13, 615

Feldman, 2011, Percutaneous repair or surgery for mitral regurgitation, N Engl J Med, 364, 1395, 10.1056/NEJMoa1009355

Fattouch, 2009, POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial, J Thorac Cardiovasc Surg, 138, 278, 10.1016/j.jtcvs.2008.11.010

Whitlow, 2012, Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study, J Am Coll Cardiol, 59, 130, 10.1016/j.jacc.2011.08.067

Wu, 2005, Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction, J Am Coll Cardiol, 45, 381, 10.1016/j.jacc.2004.09.073

Asgar, 2015, Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations, J Am Coll Cardiol, 65, 1231, 10.1016/j.jacc.2015.02.009

Obadia, 2015, The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation, EuroIntervention, 10, 1354, 10.4244/EIJV10I11A232

Grigioni, 2001, Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment, Circulation, 103, 1759, 10.1161/01.CIR.103.13.1759

Lancellotti, 2005, Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation, Eur Heart J, 26, 1528, 10.1093/eurheartj/ehi189

Trichon, 2003, Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure, Am J Cardiol, 91, 538, 10.1016/S0002-9149(02)03301-5

Rossi, 2011, Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy, Heart, 97, 1675, 10.1136/hrt.2011.225789

Mihaljevic, 2007, Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation, J Am Coll Cardiol, 49, 2191, 10.1016/j.jacc.2007.02.043

Harris, 2002, Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve?, Ann Thorac Surg, 74, 1468, 10.1016/S0003-4975(02)03920-6

Benedetto, 2009, Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients, J Cardiovasc Med (Hagerstown), 10, 109, 10.2459/JCM.0b013e32831c84b0

Deja, 2012, Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial, Circulation, 125, 2639, 10.1161/CIRCULATIONAHA.111.072256

Cohn, 1995, The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement, Eur J Cardiothorac Surg, 9, 568, 10.1016/S1010-7940(05)80008-9

Chan, 2012, Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial, Circulation, 126, 2502, 10.1161/CIRCULATIONAHA.112.143818

Lim, 2013, Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair, J Am Coll Cardiol, 64, 182, 10.1016/j.jacc.2013.10.021

van Geldorp, 2009, Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk, J Thorac Cardiovasc Surg, 137, 881, 10.1016/j.jtcvs.2008.09.028

Glaser, 2016, Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years, Eur Heart J, 37, 2658, 10.1093/eurheartj/ehv580

Chikwe, 2015, Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years, JAMA, 313, 1435, 10.1001/jama.2015.3164

McClure, 2014, Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position: a propensity-matched analysis, J Thorac Cardiovasc Surg, 148, 1931, 10.1016/j.jtcvs.2013.12.042

Chiang, 2014, Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years, JAMA, 312, 1323, 10.1001/jama.2014.12679

Repack, 2016, Comparison of quality of life perceived by patients with bioprosthetic versus mechanical valves after composite aortic root replacement, Cardiology, 133, 3, 10.1159/000438783

Dunning, 2011, Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use—an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database, J Thorac Cardiovasc Surg, 142, 776, 10.1016/j.jtcvs.2011.04.048

Rahimtoola, 2010, Choice of prosthetic heart valve in adults an update, J Am Coll Cardiol, 55, 2413, 10.1016/j.jacc.2009.10.085

Weber, 2012, Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age, J Thorac Cardiovasc Surg, 144, 1075, 10.1016/j.jtcvs.2012.01.024

Bourguignon, 2015, Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position, Ann Thorac Surg, 99, 831, 10.1016/j.athoracsur.2014.09.030

Bourguignon, 2014, Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations, J Thorac Cardiovasc Surg, 148, 2004, 10.1016/j.jtcvs.2014.02.050

Ye, 2015, Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an eight-year single-center experience, J Am Coll Cardiol Intv, 8, 1735, 10.1016/j.jcin.2015.08.012

Dvir, 2012, Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry, Circulation, 126, 2335, 10.1161/CIRCULATIONAHA.112.104505

Dvir, 2014, Transcatheter aortic valve implantation in failed bioprosthetic surgical valves, JAMA, 312, 162, 10.1001/jama.2014.7246

Hammermeister, 2000, Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial, J Am Coll Cardiol, 36, 1152, 10.1016/S0735-1097(00)00834-2

Chan, 2006, Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement, J Thorac Cardiovasc Surg, 131, 1267, 10.1016/j.jtcvs.2005.11.052

Kaneko, 2014, Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old, J Thorac Cardiovasc Surg, 147, 117, 10.1016/j.jtcvs.2013.08.028

Badhwar, 2012, Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients, Ann Thorac Surg, 93, 748, 10.1016/j.athoracsur.2011.12.032

Brown, 2008, Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses, J Thorac Cardiovasc Surg, 135, 878, 10.1016/j.jtcvs.2007.10.065

Kulik, 2006, Mechanical versus bioprosthetic valve replacement in middle-aged patients, Eur J Cardiothorac Surg, 30, 485, 10.1016/j.ejcts.2006.06.013

Bourguignon, 2015, Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 60 or younger, Ann Thorac Surg, 100, 853, 10.1016/j.athoracsur.2015.03.105

McClure, 2010, Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients, Ann Thorac Surg, 89, 1410, 10.1016/j.athoracsur.2010.01.046

Banbury, 2002, Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis, Ann Thorac Surg, 73, 1460, 10.1016/S0003-4975(02)03445-8

Borger, 2006, Twenty-year results of the Hancock II bioprosthesis, J Heart Valve Dis, 15, 49

Dellgren, 2002, Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis, J Thorac Cardiovasc Surg, 124, 146, 10.1067/mtc.2002.121672

Mykén, 2009, A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis, J Thorac Cardiovasc Surg, 137, 76, 10.1016/j.jtcvs.2008.05.068

Charitos, 2012, Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: an update on the German Dutch Ross Registry, J Thorac Cardiovasc Surg, 144, 813, 10.1016/j.jtcvs.2012.07.005

El-Hamamsy, 2010, Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial, Lancet, 376, 524, 10.1016/S0140-6736(10)60828-8

Mokhles, 2012, Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study, Eur Heart J, 33, 2213, 10.1093/eurheartj/ehs173

Edmunds, 1987, Thrombotic and bleeding complications of prosthetic heart valves, Ann Thorac Surg, 44, 430, 10.1016/S0003-4975(10)63816-7

Tiede, 1998, Modern management of prosthetic valve anticoagulation, Mayo Clin Proc, 73, 665, 10.1016/S0025-6196(11)64893-3

Aziz, 2011, Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care, J Vasc Surg, 54, 1404, 10.1016/j.jvs.2011.05.021

Chiquette, 1998, Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs, Arch Intern Med, 158, 1641, 10.1001/archinte.158.15.1641

Wittkowsky, 2006, Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting, Chest, 130, 1385, 10.1378/chest.130.5.1385

Lalonde, 2008, Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial, Am Heart J, 156, 148, 10.1016/j.ahj.2008.02.009

Witt, 2005, Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy, Chest, 127, 1515, 10.1378/chest.127.5.1515

Locke, 2005, Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service, Pharmacotherapy, 25, 685, 10.1592/phco.25.5.685.63582

Whitlock, 2012, Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e576S, 10.1378/chest.11-2305

Cannegieter, 1994, Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses, Circulation, 89, 635, 10.1161/01.CIR.89.2.635

Cannegieter, 1995, Optimal oral anticoagulant therapy in patients with mechanical heart valves, N Engl J Med, 333, 11, 10.1056/NEJM199507063330103

Schlitt, 2003, Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA), Thromb Res, 109, 131, 10.1016/S0049-3848(03)00143-9

Stein, 2001, Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves, Chest, 119, 220S, 10.1378/chest.119.1_suppl.220S

Sun, 2009, Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends, Lancet, 374, 565, 10.1016/S0140-6736(09)60780-7

Acar, 1996, AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves, Circulation, 94, 2107, 10.1161/01.CIR.94.9.2107

Hering, 2005, Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study, Chest, 127, 53, 10.1378/chest.127.1.53

Torella, 2010, LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the “LOWERING-IT” Trial, Am Heart J, 160, 171, 10.1016/j.ahj.2010.05.005

Horstkotte, 1995, Intracardiac thrombosis: patient-related and device-related factors, J Heart Valve Dis, 4, 114

Pruefer, 2001, Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5), Eur Heart J Suppl, 3, Q39, 10.1016/S1520-765X(01)90041-0

Meschengieser, 1997, Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves, J Thorac Cardiovasc Surg, 113, 910, 10.1016/S0022-5223(97)70264-2

Turpie, 1993, A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement, N Engl J Med, 329, 524, 10.1056/NEJM199308193290802

Aramendi, 2005, Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial, Eur J Cardiothorac Surg, 27, 854, 10.1016/j.ejcts.2004.12.064

Colli, 2007, Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial, J Heart Valve Dis, 16, 667

Heras, 1995, High risk of thromboemboli early after bioprosthetic cardiac valve replacement, J Am Coll Cardiol, 25, 1111, 10.1016/0735-1097(94)00563-6

Nuñez, 1984, Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis, Ann Thorac Surg, 37, 84, 10.1016/S0003-4975(10)60717-5

Brennan, 2012, Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database, J Am Coll Cardiol, 60, 971, 10.1016/j.jacc.2012.05.029

Egbe, 2015, Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors, J Am Coll Cardiol, 66, 2285, 10.1016/j.jacc.2015.09.022

Mérie, 2012, Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding, JAMA, 308, 2118, 10.1001/jama.2012.54506

Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561

Douketis, 2015, Perioperative bridging anticoagulation in patients with atrial fibrillation, N Engl J Med, 373, 823, 10.1056/NEJMoa1501035

Eikelboom, 2013, Dabigatran versus warfarin in patients with mechanical heart valves, N Engl J Med, 369, 1206, 10.1056/NEJMoa1300615

Giugliano, 2013, Edoxaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 369, 2093, 10.1056/NEJMoa1310907

Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039

Makkar, 2015, Possible subclinical leaflet thrombosis in bioprosthetic aortic valves, N Engl J Med, 373, 2015, 10.1056/NEJMoa1509233

Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638

Sundt, 2005, Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?, J Thorac Cardiovasc Surg, 129, 1024, 10.1016/j.jtcvs.2004.11.028

Russo, 2008, Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications, J Am Coll Cardiol, 51, 1203, 10.1016/j.jacc.2007.10.058

ElBardissi, 2010, Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?, J Thorac Cardiovasc Surg, 139, 1137, 10.1016/j.jtcvs.2009.10.064

Levine, 2016, 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 68, 1082, 10.1016/j.jacc.2016.03.513

Puskas, 2014, Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized On-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial, J Thorac Cardiovasc Surg, 147, 1202, 10.1016/j.jtcvs.2014.01.004

Hansson, 2016, Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications, J Am Coll Cardiol, 68, 2059, 10.1016/j.jacc.2016.08.010

Pache, 2016, Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves, Eur Heart J, 37, 2263, 10.1093/eurheartj/ehv526

FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves. December 19, 2012. 2012.

Van de Werf, 2012, A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN), Am Heart J, 163, 931, 10.1016/j.ahj.2012.03.011

Douketis, 2012, Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Erratum, Chest, 141, e326S, 10.1378/chest.11-2298

Pengo, 2007, Clin Appl Thromb Hemost, 13, 241, 10.1177/1076029607302544

Barbetseas, 1998, Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters, J Am Coll Cardiol, 32, 1410, 10.1016/S0735-1097(98)00385-4

Gündüz, 2015, Sixty-four-section cardiac computed tomography in mechanical prosthetic heart valve dysfunction: thrombus or pannus, Circ Cardiovasc Imaging, 8, e003246, 10.1161/CIRCIMAGING.115.003246

Cianciulli, 2005, Cinefluoroscopic assessment of mechanical disc prostheses: its value as a complementary method to echocardiography, J Heart Valve Dis, 14, 664

Montorsi, 2000, Role of cine-fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected prosthetic heart valve thrombosis, Am J Cardiol, 85, 58, 10.1016/S0002-9149(99)00607-4

Muratori, 2006, Feasibility and diagnostic accuracy of quantitative assessment of mechanical prostheses leaflet motion by transthoracic and transesophageal echocardiography in suspected prosthetic valve dysfunction, Am J Cardiol, 97, 94, 10.1016/j.amjcard.2005.07.112

Suh, 2016, Added value of cardiac computed tomography for evaluation of mechanical aortic valve: emphasis on evaluation of pannus with surgical findings as standard reference, Int J Cardiol, 214, 454, 10.1016/j.ijcard.2016.04.011

Symersky, 2009, Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction, Am J Cardiol, 104, 1128, 10.1016/j.amjcard.2009.05.061

Gürsoy, 2013, The incremental value of RT three-dimensional TEE in the evaluation of prosthetic mitral valve ring thrombosis complicated with thromboembolism, Echocardiography, 30, E198, 10.1111/echo.12246

Tong, 2004, Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry, J Am Coll Cardiol, 43, 77, 10.1016/j.jacc.2003.08.028

Keuleers, 2011, Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis, Am J Cardiol, 107, 275, 10.1016/j.amjcard.2010.09.013

Roudaut, 2009, Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases, Arch Cardiovasc Dis, 102, 269, 10.1016/j.acvd.2009.01.007

Karthikeyan, 2009, Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial, Circulation, 120, 1108, 10.1161/CIRCULATIONAHA.109.876706

Cáceres-Lóriga, 2006, Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients, J Thromb Thrombolysis, 21, 185, 10.1007/s11239-006-4969-y

Özkan, 2013, Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial, J Am Coll Cardiol Img, 6, 206, 10.1016/j.jcmg.2012.10.016

Nagy, 2009, Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events, J Heart Valve Dis, 18, 268

Özkan, 2013, Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator, Circulation, 128, 532, 10.1161/CIRCULATIONAHA.113.001145

Deviri, 1991, Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management, J Am Coll Cardiol, 17, 646, 10.1016/S0735-1097(10)80178-0

Karthikeyan, 2013, Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies, Eur Heart J, 34, 1557, 10.1093/eurheartj/ehs486

Huang, 2013, Treatment of obstructive thrombosed prosthetic heart valve, J Am Coll Cardiol, 62, 1731, 10.1016/j.jacc.2013.07.075

Özkan, 2015, Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial, Am Heart J, 170, 409, 10.1016/j.ahj.2015.04.025

Laschinger, 2015, Reduced leaflet motion in bioprosthetic aortic valves—the FDA perspective, N Engl J Med, 373, 1996, 10.1056/NEJMp1512264

Pibarot, 2009, Prosthetic heart valves: selection of the optimal prosthesis and long-term management, Circulation, 119, 1034, 10.1161/CIRCULATIONAHA.108.778886

Koene, 2013, Impact of prosthesis-patient mismatch on early and late mortality after aortic valve replacement, J Cardiothorac Surg, 8, 96, 10.1186/1749-8090-8-96

Maganti, 2009, Redo valvular surgery in elderly patients, Ann Thorac Surg, 87, 521, 10.1016/j.athoracsur.2008.09.030

Leontyev, 2011, Redo aortic valve surgery: early and late outcomes, Ann Thorac Surg, 91, 1120, 10.1016/j.athoracsur.2010.12.053

Kaneko, 2015, Contemporary outcomes of repeat aortic valve replacement: a benchmark for transcatheter valve-in-valve procedures, Ann Thorac Surg, 100, 1298, 10.1016/j.athoracsur.2015.04.062

Jander, 2012, Usefulness of phenprocoumon for the treatment of obstructing thrombus in bioprostheses in the aortic valve position, Am J Cardiol, 109, 257, 10.1016/j.amjcard.2011.08.038

Butnaru, 2013, Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation, Am J Cardiol, 112, 1439, 10.1016/j.amjcard.2013.06.014

Pislaru, 2015, Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series, Eur J Cardiothorac Surg, 47, 725, 10.1093/ejcts/ezu201

De Marchena, 2015, Thrombus formation following transcatheter aortic valve replacement, J Am Coll Cardiol Intv, 8, 728, 10.1016/j.jcin.2015.03.005

Latib, 2015, Treatment and clinical outcomes of transcatheter heart valve thrombosis, Circ Cardiovasc Interv, 8, 10.1161/CIRCINTERVENTIONS.114.001779

Webb, 2010, Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves, Circulation, 121, 1848, 10.1161/CIRCULATIONAHA.109.924613

Phan, 2016, Transcatheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review, J Thorac Dis, 8, E83

Administration USFaD. FDA expands use of CoreValue System for aortic “valve-in-valve replacement”. March 30, 2015. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm440535.htm. Accessed January 20, 2017.

Akins, 2005, Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks, J Heart Valve Dis, 14, 792

Miller, 1995, Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation, J Heart Valve Dis, 4, 160

Ruiz, 2011, Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks, J Am Coll Cardiol, 58, 2210, 10.1016/j.jacc.2011.03.074

Sorajja, 2011, Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients, Circ Cardiovasc Interv, 4, 314, 10.1161/CIRCINTERVENTIONS.110.960955

Sorajja, 2011, Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation, J Am Coll Cardiol, 58, 2218, 10.1016/j.jacc.2011.07.041

Botelho-Nevers, 2009, Dramatic reduction in infective endocarditis-related mortality with a management-based approach, Arch Intern Med, 169, 1290, 10.1001/archinternmed.2009.192

Gordon, 2000, Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997, Ann Thorac Surg, 69, 1388, 10.1016/S0003-4975(00)01135-8

Hasbun, 2003, Complicated left-sided native valve endocarditis in adults: risk classification for mortality, JAMA, 289, 1933, 10.1001/jama.289.15.1933

Jault, 1997, Active native valve endocarditis: determinants of operative death and late mortality, Ann Thorac Surg, 63, 1737, 10.1016/S0003-4975(97)00117-3

Kiefer, 2011, Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure, JAMA, 306, 2239, 10.1001/jama.2011.1701

Tornos, 1992, Late prosthetic valve endocarditis. Immediate and long-term prognosis, Chest, 101, 37, 10.1378/chest.101.1.37

Wang, 2007, Contemporary clinical profile and outcome of prosthetic valve endocarditis, JAMA, 297, 1354, 10.1001/jama.297.12.1354

Aksoy, 2007, Early surgery in patients with infective endocarditis: a propensity score analysis, Clin Infect Dis, 44, 364, 10.1086/510583

Chirouze, 2004, Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database, Clin Infect Dis, 38, 1323, 10.1086/383035

Ellis, 2001, Fungal endocarditis: evidence in the world literature, 1965-1995, Clin Infect Dis, 32, 50, 10.1086/317550

Hill, 2007, Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study, Eur Heart J, 28, 196, 10.1093/eurheartj/ehl427

Melgar, 1997, Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital, Medicine (Baltimore), 76, 94, 10.1097/00005792-199703000-00002

Remadi, 2007, Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis, Ann Thorac Surg, 83, 1295, 10.1016/j.athoracsur.2006.09.093

Wolff, 1995, Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision, Chest, 108, 688, 10.1378/chest.108.3.688

Anguera, 2005, Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality, Eur Heart J, 26, 288, 10.1093/eurheartj/ehi034

Chan, 2002, Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess, CMAJ, 167, 19

Jault, 1993, Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results, J Thorac Cardiovasc Surg, 105, 1106, 10.1016/S0022-5223(19)33785-7

Middlemost, 1991, A case for early surgery in native left-sided endocarditis complicated by heart failure: results in 203 patients, J Am Coll Cardiol, 18, 663, 10.1016/0735-1097(91)90785-8

Wang, 1972, Complete heart block complicating bacterial endocarditis, Circulation, 46, 939, 10.1161/01.CIR.46.5.939

Hill, 2007, Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study, Am Heart J, 154, 923, 10.1016/j.ahj.2007.06.028

Klieverik, 2009, Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses, Ann Thorac Surg, 88, 1814, 10.1016/j.athoracsur.2009.08.019

Manne, 2012, Outcomes after surgical treatment of native and prosthetic valve infective endocarditis, Ann Thorac Surg, 93, 489, 10.1016/j.athoracsur.2011.10.063

Athan, 2012, Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices, JAMA, 307, 1727, 10.1001/jama.2012.497

Ho, 2010, Prosthetic valve endocarditis in a multicenter registry of Chinese patients, Asian Cardiovasc Thorac Ann, 18, 430, 10.1177/0218492310379457

Rundström, 2004, Pacemaker endocarditis during 18 years in Göteborg, Scand J Infect Dis, 36, 674, 10.1080/00365540410022611

Sohail, 2008, Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection, Mayo Clin Proc, 83, 46, 10.4065/83.1.46

Kang, 2012, Early surgery versus conventional treatment for infective endocarditis, N Engl J Med, 366, 2466, 10.1056/NEJMoa1112843

Mügge, 1989, Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach, J Am Coll Cardiol, 14, 631, 10.1016/0735-1097(89)90104-6

Thuny, 2005, Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study, Circulation, 112, 69, 10.1161/CIRCULATIONAHA.104.493155

Eishi, 1995, Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan, J Thorac Cardiovasc Surg, 110, 1745, 10.1016/S0022-5223(95)70038-2

Barsic, 2013, Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke, Clin Infect Dis, 56, 209, 10.1093/cid/cis878

García-Cabrera, 2013, Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study, Circulation, 127, 2272, 10.1161/CIRCULATIONAHA.112.000813